Author:
Yoon Soomin,Kim Yun-Hee,Kang Se Hun,Kim Seok-Ki,Lee Hwa Kyoung,Kim Hyori,Chung Junho,Kim In-Hoo
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference33 articles.
1. Anderson K, Lai ZH, McDonald OB, Stuart JD, Nartey EN et al (2009) Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time. Biochem J 420:259–265
2. Baxter AB, Melnikoff S, Stites DP, Brasch RC (1991) Immunogenicity of gadolinium-based contrast agents for magnetic-resonance-imaging—induction and characterization of antibodies in animals. Invest Radiol 26:1035–1040
3. Behr TM, Gotthardt M, Becker W, Behe M (2002) Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy—a review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience. Nuklearmedizin-Nucl Med 41:71–79
4. Boerman OC, van Schaijk FG, Oyen WJG, Corstens FHM (2003) Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med 44:400–411
5. Bowman Edward R, Herbert McKennis J (1962) Studies on the metabolism of (−)-cotinine in the human. J Pharmacol Exp Ther 135:306